Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers-Reference-Cited by-同舟云学术

Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers

Published:2019-11-12 Issue:1 Volume:24 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Paulsen Grant¹²^ORCID,Michaels Marian G.³,Danziger‐Isakov Lara¹²^ORCID,Dipchand Anne I.⁴^ORCID,Green Michael³^ORCID,McCulloch Mignon⁵

Affiliation:

1. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH USA

2. Division of Pediatric Infectious Diseases Cincinnati Children's Hospital Medical Center Cincinnati OH USA

3. Division of Pediatric Infectious Diseases Department of Pediatrics UPMC Children's Hospital of Pittsburgh Pittsburgh PA USA

4. Division of Cardiology Department of Pediatrics Hospital for Sick Children University of Toronto Toronto ON Canada

5. Department of Paediatric Renal and Solid Organ Transplantation, Red Cross Children's Hospital University of Cape Town Cape Town South Africa

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13609

Reference9 articles.

1. Clinical conditions associated with PCP in children

2. Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients;Stern A;Cochrane Database Syst Rev,2014

3. PneumocystisPneumonia in Solid Organ Transplantation

4. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

5. KDIGO clinical practice guideline for the care of kidney transplant recipients;Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group;Am J Transplant,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study;International Journal of Antimicrobial Agents;2024-05

2. Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients;American Journal of Transplantation;2023-12

3. Low-Dose TMP-SMX for Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Solid Organ Transplant Recipients;The Journal of Pediatric Pharmacology and Therapeutics;2023-04-01

4. Considerations and controversies of pharmacologic management of the pediatric kidney transplant recipient;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-01

5. Rejection Challenges: Diagnosis and Management;Challenges in Pediatric Kidney Transplantation;2021